Jie Ji - Publications

Comparison of the efficacy of pre-transplant and post-transplant antithymocyte globulin combined with post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in myeloablative haploidentical peripheral blood stem cell transplantation.

Journal: Cell transplantation

Published: June 01, 2026

Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.

Journal: American journal of hematology

Published: February 04, 2026

Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case series.

Journal: Frontiers in oncology

Published: December 07, 2025

Venetoclax combined with chidamide and decitabine successfully induced remission in relapsed/refractory classical Hodgkin lymphoma: a case report and literature review.

Journal: Frontiers in immunology

Published: November 29, 2025

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

Journal: Blood

Published: November 25, 2025

Clinical study of recombinant human thrombopoietin in platelet engraftment following autologous hematopoietic stem cell transplantation.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: November 24, 2025

Hetrombopag for enhancement of platelet engraftment after allogeneic hematopoietic stem cell transplantation: A single-center experience.

Journal: Therapeutic advances in hematology

Published: September 01, 2025

In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia.

Journal: Leukemia

Published: May 22, 2025

Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell Transplantation.

Journal: MedComm

Published: March 25, 2025

Integration of anti-PD-1 antibody into chemotherapeutic regimens improved the outcome of aggressive NK cell leukemia: a single-center retrospective real-world analysis.

Journal: Frontiers in immunology

Published: February 14, 2025

Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 01, 2025

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis.

Journal: Advances in therapy

Published: October 30, 2024